4-(4-CARBAMOYL-2-METHOXYPHENYL)-5-ETHOXY-2,8-DIMETHYL-1,4-DIHYDRO-1,6-NAPHTHYRIDINE-3-CARBOXAMIDE
UNII ZP8NZ4Y5F4
Substance Identification & Data
This profile provides standardized clinical and technical data for 4-(4-carbamoyl-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide, uniquely identified by the FDA Unique Ingredient Identifier (UNII) ZP8NZ4Y5F4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 3046142-41-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H24N4O4 FSYSRIMQNVPEBN-UHFFFAOYSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 4-(4-carbamoyl-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.